Naltrexone in low doses - Hope for better treatment of MANY diseases

Naltrexone in low doses - Hope for better treatment of MANY diseases

“Low-dose naltrexone, internationally known as LDN, treats patients with Crohn's disease, Alzheimer's disease, ovarian cancer, pancreatic cancer, liver cancer, autism and multiple sclerosis, among other serious conditions. Naltrexone is a pharmacologically active opiate antagonist. It was first used in relatively high doses for the treatment of opioids and alcohol. But at very low doses, naltrexone was found to have immunomodulatory properties.

LDN was first used as a therapeutic agent for people with AIDS. It has been proposed for use in people with malignancies, multiple sclerosis, and autoimmune diseases. A recent publication showed a significant improvement in Crohn's disease in people who used LDN.

According to physician Dr. Joseph Mercola: “Low dose naltrexone (LDN) holds promise for helping millions of people with cancer and autoimmune diseases. As a pharmacologically active opioid antagonist, LDN works by blocking opioid receptors, which in turn helps activate your body's immune system. Some leading experts believe that low-dose Naltrexone holds great promise for the treatment of millions of people suffering from autoimmune diseases, central nervous system disorders, and even cancer and HIV/AIDS. It is extremely cheap, and appears to be free of harmful side effects.”

Physician Dr. Jacquelyn McCandless reports finding positive effects in children with autism using LDN therapy. Physician Dr. Burton M. Berkson attests that he has achieved phenomenal results with low-dose naltrexone (LDN) in patients with cancer and autoimmune diseases” (Gustavo Molina Buzz and Júlio Caleiro Pimenta).

Read it - it may help you or people you know in need:

🔗 https://www.lowdosenaltrexone.org/

🔗 https://www.ldnscience.org/